A detailed history of Cibc World Markets Corp transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Cibc World Markets Corp holds 35,309 shares of AMRX stock, worth $253,165. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35,309
Previous 14,892 137.1%
Holding current value
$253,165
Previous $117,000 152.14%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025

BUY
$7.72 - $9.01 $157,619 - $183,957
20,417 Added 137.1%
35,309 $295,000
Q4 2024

Feb 10, 2025

BUY
$7.69 - $9.25 $114,519 - $137,751
14,892 New
14,892 $117,000

Others Institutions Holding AMRX

About Amneal Pharmaceuticals, Inc.


  • Ticker AMRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 151,408,992
  • Market Cap $1.09B
  • Description
  • Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...
More about AMRX
Track This Portfolio

Track Cibc World Markets Corp Portfolio

Follow Cibc World Markets Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Markets Corp, based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Markets Corp with notifications on news.